opentargets-database

To validate drug targets, use the Open Targets Platform API to assess target tractability, safety liabilities, and biological relevance. It integrates human genetics, omics, and clinical drug data to support systematic target prioritization for drug discovery.

Evaluating druggability and safety profiles involves querying the Open Targets Platform API to retrieve tractability and safety liability data. This integrates genetic and molecular evidence to assess target-disease associations for drug development.

Yes, you can gather evidence supporting target-disease associations from biomedical literature. The Skill queries the Open Targets Platform API to retrieve diverse evidence types by integrating literature, human genetics, omics, and clinical drug data.

Yes, querying the Open Targets API for target identification requires the requests library. This dependency facilitates accessing the platform to integrate biomedical data for target discovery, validation, and prioritization.

Target prioritization integrates clinical drug data with pharmacology evidence by querying the Open Targets API. It systematically combines human genetics, omics, and literature evidence to validate and prioritize potential therapeutic drug targets.